Pharmacotherapy and behavioral intervention for peripheral arterial disease

Area of Science:

• Vascular Medicine
• Cardiovascular Disease Epidemiology

Background:

• Lower-extremity peripheral arterial disease (PAD) is a widespread manifestation of systemic atherosclerosis.
• Affecting over 10 million US adults, PAD is often underdiagnosed due to symptom attribution to aging or incomplete medical assessments.
• The hallmark symptom, intermittent claudication, signifies functional limitation and predicts severe cardiovascular events.

Purpose of the Study:

• To highlight the prevalence and diagnostic challenges of peripheral arterial disease.
• To emphasize the prognostic significance of intermittent claudication.
• To outline a comprehensive, team-based approach to managing PAD and reducing cardiovascular mortality.

Main Methods:

• Literature review and synthesis of epidemiological data on PAD.
• Analysis of the clinical presentation and diagnostic criteria for intermittent claudication.
• Description of current treatment strategies for PAD symptom management and cardiovascular risk reduction.

Main Results:

• PAD is a prevalent condition with significant underdiagnosis.
• Intermittent claudication is a key symptom associated with increased risk of myocardial infarction, stroke, and cardiovascular death.
• Effective management requires a multidisciplinary approach targeting both disease progression and overall cardiovascular risk.

Conclusions:

• Comprehensive patient assessment is vital for diagnosing PAD.
• Integrated treatment strategies are essential for managing PAD symptoms and mitigating life-threatening cardiovascular events.
• Patient, family, and healthcare professional collaboration optimizes outcomes for individuals with peripheral arterial disease.